Hatteras Venture Partners has secured over $200 million across a pair of funds that are set to benefit up-and-coming biotechs ...

Bristol Myers' Breyanzi sales surged 125% in Q2 to $344M, fueled by new approvals, strong demand and expanded market reach.

Major indices were in the green early on Wednesday, with the S&P 500 and Nasdaq Composite building on yesterday's ...